on 29 Oct 2015
Last Applicant/ Owned by
International Myeloma Foundation
12650 Riverside Drive, Suite 206 North Hollywood CA 91607
, ,
Serial Number
UK00801296279 filed on 29th Oct 2015
Registration Number
UK00801296279 registered on
30th Sept 2016
Correspondent Information
Natasha Shabani Greenberg Glusker Fields Claman & Machtinger LLP
1900 Avenue of the Stars, 21st Floor Los Angeles CA 90067
,
Downloadable fact sheets in the field of myeloma research, diagnosis and treatment; downloadable podcasts in the field of myeloma research, diagnosis and treatment; downloadable webcasts in the field of myeloma research, diagnosis and treatment; downloadable webinars in the field of myeloma research, diagnosis and treatment; downloadable written articles in the field of myeloma research, diagnosis and treatment; electronic publications, namely, newsletters, journals, manuals and pamphlets featuring information on myeloma research, diagnosis and treatment recorded on computer media.
Printed educational materials in the field of myeloma research, diagnosis and treatment.
Association services, namely, promoting the public interest and awareness in cancer research and education (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations); association services, namely, promoting public awareness of myeloma research, diagnosis and treatment, and the need for access to a broad range of approved and medically-accepted anticancer regimens (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations); promoting awareness of the need for access to a broad range of approved and medically-accepted anticancer regimens (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations); promoting collaboration within the scientific, research and provider communities to achieve advances in the field of myeloma research, diagnosis and treatment (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations); public advocacy to promote awareness of the need for access to a broad range of approved and medically-accepted anticancer regimens (terms considered too vague by the International Bureau - rule 13.2.b) of the Common Regulations).
Charitable fundraising; providing grants for research in the field of myeloma.
Arranging and conducting educational conferences; conducting workshops and seminars in the field of myeloma research, diagnosis and treatment; education services, namely, providing seminars, conferences, workshops and symposia in the field of myeloma research, diagnosis and treatment; electronic publishing services, namely, publication of text and graphic works of others on DVD, CD and online featuring information about myeloma.
Developing quality control standards for the treatment and care of myeloma patients; development of voluntary standards for the treatment and care of myeloma patients.
UK00801296279
Figurative
Individual